Video Experimental Relacionado
Updated: Jul 27, 2026
06:18
Syntheses, Crystallization, and Spectroscopic Characterization of 3,5-Lutidine N-Oxide Dehydrate
Published on: April 24, 2018
Formulación anhidra de cloruro de aluminio para la foliculitis crónica
JAMA
|October 24, 1980
Resumen
Una solución de cloruro de aluminio al 6,25% en alcohol etílico trata eficazmente la foliculitis crónica. Este tratamiento tópico es particularmente prometedor para la foliculitis de glúteos.
Área de la Ciencia:
- Dermatología Dermatología dermatología.
- Terapéutica tópica para el tratamiento tópico.
Sus antecedentes:
- La foliculitis crónica es una inflamación persistente de la piel.
- Las opciones de tratamiento para la foliculitis localizada pueden ser limitadas.
Objetivo del estudio:
- Evaluar la eficacia del cloruro de aluminio como tratamiento tópico para la foliculitis crónica.
Principales métodos:
- Se preparó una solución de alcohol etílico anidro que contenía 6,25% de cloruro de aluminio.
- La solución se aplicó localmente para tratar la foliculitis crónica.
Principales resultados:
- La solución de cloruro de aluminio demostró una alta eficacia en el tratamiento de la foliculitis crónica.
- El tratamiento fue especialmente eficaz para la foliculitis localizada en las nalgas.
Conclusiones:
- El cloruro de aluminio tópico ofrece una opción terapéutica prometedora para la foliculitis crónica.
- Este tratamiento es particularmente beneficioso para la foliculitis de glúteos.
Videos de Conceptos Relacionados
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:21Drugs for Treatment of Constipation-Predominant IBS
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:26Tonsillitis II: Management
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
01:20Candidiasis
Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...